Role of the Immune System in Hypertensive Target Organ Damage

Trends in Cardiovascular Medicine

Volumn 19, Issue 7, 2009, Pages 242-246

  Kvakan, Heda ^a,b   Luft, Friedrich C ^a,b   Muller, Dominik N ^b  

^a FRANZ VOLHARD CLINIC   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; ETANERCEPT; HELIX LOOP HELIX PROTEIN; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 2; INTERCELLULAR ADHESION MOLECULE 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ATHEROSCLEROSIS; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; DISEASE MARKER; DISEASE MODEL; GENE EXPRESSION; HUMAN; HYPERTENSION; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY DISEASE; KIDNEY INJURY; NONHUMAN; ORGAN INJURY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RENIN ANGIOTENSIN DISORDER; REVIEW; TARGET ORGAN; TRANSCRIPTION REGULATION;

ANTIHYPERTENSIVE AGENTS; HEART DISEASES; HUMANS; HYPERTENSION; IMMUNE SYSTEM; IMMUNOSUPPRESSION; T-LYMPHOCYTES, REGULATORY;

EID: 77951279775     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.02.004     Document Type: Review

References (43)

1. Ait-Oufella H., Salomon B.L., Potteaux S., et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006, 12:178-180.
2. Amuchastegui S.C., Azzollini N., Mister M., Pezzotta A., et al. Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. J Am Soc Nephrol 1998, 9:1948-1955.
3. Bohlender J., Fukamizu A., Lippoldt A., Nomura T., et al. High human renin hypertension in transgenic rats. Hypertension 1997, 29:428-434.
4. Braunersreuther V., Zernecke A., Arnaud C., et al. Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2007, 27:373-379.
5. Bush E., Maeda N., Kuziel W.A., Dawson T.C., et al. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension 2000, 36:360-363.
6. Chua C.C., Hamdy R.C., Chua B.H. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1998, 1401:187-194.
7. Crowley S.D., Frey C.W., Gould S.K., et al. Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am J Physiol Renal Physiol 2008, 295:F515-F524.
8. Crowley S.D., Vasievich M.P., Ruiz P., et al. Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis. J Clin Invest 2009, 119:943-953.
9. Furukawa Y., Matsumori A., Hirozane T., Sasayama S. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. Circulation 1996, 93:333-339.
10. Gimbrone M.A., Alexander R.W. Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium. Science 1975, 189:219-220.
11. Godsel L.M., Leon J.S., Wang K., Fornek J.L., et al. Captopril prevents experimental autoimmune myocarditis. J Immunol 2003, 171:346-352.
12. Gratze P., Dechend R., Stocker C., et al. Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension. Circulation 2008, 117:2645-2656.
13. Guzik T.J., Hoch N.E., Brown K.A., McCann L.A., et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007, 204:2449-2460.
14. Hernandez-Presa M.A., Bustos C., Ortego M., Tunon J., et al. ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis. Am J Pathol 1998, 153:1825-1837.
15. Hisada Y., Sugaya T., Yamanouchi M., Uchida H., et al. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 1999, 103:627-635.
16. Hoch N.E., Guzik T.J., Chen W., Deans T., et al. Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol 2009, 296:R208-R216.
17. Ishibashi M., Hiasa K., Zhao Q., et al. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ Res 2004, 94:1203-1210.
18. Jurewicz M., McDermott D.H., Sechler J.M., et al. Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. J Am Soc Nephrol 2007, 18:1093-1102.
19. + T-cell subset. Blood 2005, 105:2877-2886.
20. + Treg free of contaminating effector cells. Blood 2009, 113:827-836.
21. Kvakan H., Kleinewietfeld M., Qadri F., et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 2009, 119:2904-2912.
22. Luft F.C., Mervaala E., Muller D.N., et al. Hypertension-induced end-organ damage: a new transgenic approach to an old problem. Hypertension 1999, 33:212-218.
23. + regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol 2006, 17:2731-2741.
24. Mattson D.L., James L., Berdan E.A., Meister C.J. Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 2006, 48:149-156.
25. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol 2004, 172:4676-4680.
26. + regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:893-900.
27. + regulatory T cells. Arthritis Rheum 2005, 52:2212-2221.
28. Muller D.N., Dechend R., Mervaala E.M., et al. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 2000, 35:193-201.
29. Muller D.N., Heissmeyer V., Dechend R., et al. Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage. Faseb J 2001, 15:1822-1824.
30. Muller D.N., Shagdarsuren E., Park J.K., et al. Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol 2002, 161:1679-1693.
31. Nataraj C., Oliverio M.I., Mannon R.B., et al. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest 1999, 104:1693-1701.
32. Nishida M., Fujinaka H., Matsusaka T., et al. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest 2002, 110:1859-1868.
33. Platten M., Youssef S., Hur E.M., et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci U S A 2009, 106:14948-14953.
34. + regulatory T cells and their therapeutic potential. Annu Rev Med 2006, 57:381-402.
35. Roncarolo M.G., Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007, 7:585-598.
36. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
37. Schieffer B., Luchtefeld M., Braun S., et al. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 2000, 87:1195-1201.
38. Schultz J.E., Witt S.A., Nieman M.L., et al. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J Clin Invest 1999, 104:709-719.
39. Stegbauer J., Lee D.H., Seubert S., et al. Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc Natl Acad Sci U S A 2009, 106:14942-14947.
40. Suntharalingam G., Perry M.R., Ward S., et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006, 355:1018-1028.
41. + splenocytes that delays adoptive transfer of diabetes expresses l-selectin and high levels of CCR7. J Immunol 2002, 169:2461-2465.
42. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532.
43. Wood K.J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003, 3:199-210.